We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-2.12%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$284B
AUM Growth
-$3.39B
Cap. Flow
-$3.28B
Cap. Flow %
-1.16%
Top 10 Hldgs %
25.31%
Holding
3,279
New
74
Increased
1,024
Reduced
1,721
Closed
74

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$580M
2
INTC icon
Intel
INTC
+$382M
3
ZTS icon
Zoetis
ZTS
+$256M
4
PM icon
Philip Morris
PM
+$225M
5
HON icon
Honeywell
HON
+$208M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$562M
2
RTX icon
RTX Corp
RTX
+$425M
3
AAPL icon
Apple
AAPL
+$365M
4
UNP icon
Union Pacific
UNP
+$312M
5
MSFT icon
Microsoft
MSFT
+$254M

Sector Composition

Rank Sector Weight
1 Technology 26.53%
2 Healthcare 12.08%
3 Financials 11.17%
4 Consumer Discretionary 10.62%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTLB icon
1326
GitLab
GTLB
$6.58B
$12.4M ﹤0.01%
273,403
+134,845
+97% +$6.46M
WIX icon
1327
WIX.com
WIX
$2.52B
$12.4M ﹤0.01%
134,594
-293
-0.2% -$26.2K
RNST icon
1328
Renasant Corp
RNST
$3.91B
$12.3M ﹤0.01%
470,814
-172,382
-27% -$4.85M
PSMT icon
1329
Pricesmart
PSMT
$5.46B
$12.3M ﹤0.01%
165,440
+6,926
+4% +$535K
SKY icon
1330
Champion Homes
SKY
$5.14B
$12.3M ﹤0.01%
192,882
-42,278
-18% -$2.84M
JRVR icon
1331
James River Group Holdings
JRVR
$217M
$12.3M ﹤0.01%
798,213
+53,667
+7% +$875K
CRNX icon
1332
Crinetics Pharmaceuticals
CRNX
$8.92B
$12.2M ﹤0.01%
410,941
+67,762
+20% +$1.4M
WTM icon
1333
White Mountains Insurance
WTM
$5.13B
$12.2M ﹤0.01%
8,139
-138
-2% -$212K
MRTX
1334
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$12.1M ﹤0.01%
278,441
+46,556
+20% +$1.66M
CNM icon
1335
Core & Main
CNM
$8.71B
$12.1M ﹤0.01%
419,370
+13,211
+3% +$408K
CSR
1336
Centerspace
CSR
$952M
$12.1M ﹤0.01%
200,726
+7,440
+4% +$465K
LAZ icon
1337
Lazard
LAZ
$4.31B
$12.1M ﹤0.01%
389,757
+141,339
+57% +$4.74M
YOU icon
1338
Clear Secure
YOU
$5.28B
$12.1M ﹤0.01%
633,749
-286,199
-31% -$6.34M
RXST icon
1339
RxSight
RXST
$260M
$12M ﹤0.01%
431,477
+310,992
+258% +$9.27M
G icon
1340
Genpact
G
$5.76B
$12M ﹤0.01%
330,675
-224,055
-40% -$8.32M
SNV
1341
DELISTED
Synovus
SNV
$12M ﹤0.01%
430,334
+2,218
+0.5% +$69.4K
VRTS icon
1342
Virtus Investment Partners
VRTS
$1.1B
$11.9M ﹤0.01%
59,066
-158
-0.3% -$32.2K
NAVI icon
1343
Navient
NAVI
$853M
$11.9M ﹤0.01%
691,217
+145,016
+27% +$2.61M
BHVN icon
1344
Biohaven
BHVN
$2.21B
$11.9M ﹤0.01%
456,111
+47,786
+12% +$993K
GBCI icon
1345
Glacier Bancorp
GBCI
$6.35B
$11.8M ﹤0.01%
415,109
-107,501
-21% -$3.33M
RYN icon
1346
Rayonier
RYN
$6.55B
$11.8M ﹤0.01%
457,555
-1,628
-0.4% -$45.4K
QDEL icon
1347
QuidelOrtho
QDEL
$838M
$11.8M ﹤0.01%
161,620
-30,943
-16% -$2.47M
DLX icon
1348
Deluxe
DLX
$1.15B
$11.8M ﹤0.01%
623,964
-54,431
-8% -$1.06M
NWE icon
1349
NorthWestern Energy
NWE
$4.43B
$11.7M ﹤0.01%
244,402
+73,992
+43% +$3.94M
RH icon
1350
RH
RH
$3.71B
$11.7M ﹤0.01%
44,429
-2,575
-5% -$895K

Similar funds

Nuveen's Q3 2023 Portfolio in Review

As of Q3 2023, Nuveen held 3,279 positions worth $284B, down 1.2% from $287B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.5%. Nuveen opened 74 new positions and exited 74, leaving the 3,279-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q3 2023 buy was Primo Water Corporation: 4,446,437 shares worth $61.4M.
  • Nuveen added most to Kenvue in Q3 2023, an estimated $580M increase.
  • Nuveen's biggest Q3 2023 reduction was PepsiCo, cutting an estimated $562M.
  • Nuveen fully exited Life Storage, Inc. in Q3 2023, selling an estimated $77.3M.
  • Nuveen's ten largest holdings make up 25% of its $284B portfolio in Q3 2023.
  • Nuveen opened 74 new positions and closed 74 in Q3 2023.
  • Nuveen's portfolio value fell 1.2% quarter-over-quarter to $284B.

Based on Nuveen's 13F filing for Q3 2023, filed 14 Nov 2023.